Comparative Pharmacology
Head-to-head clinical analysis: LACTATED RINGER S AND DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LACTATED RINGER S AND DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER vs NORMOSOL-R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactated Ringer's and Dextrose 5% is a crystalloid solution that provides fluid, electrolytes, and calories. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity. Dextrose is metabolized to carbon dioxide and water, providing energy. The solution expands extracellular fluid volume and replaces electrolyte deficits.
Normosol-R is an isotonic crystalloid solution that replaces extracellular fluid volume and electrolytes. It provides sodium, chloride, potassium, magnesium, acetate, and gluconate to maintain acid-base balance and osmotic equilibrium. Acetate and gluconate are metabolized to bicarbonate, providing an alkalinizing effect.
Intravenous infusion; adult dose is 500-1000 mL at a rate of 5-10 mL/kg/hour, adjusted based on clinical response, fluid status, and serum glucose/electrolytes. Usual max rate 30 mL/kg/day or 2000 mL/day unless otherwise indicated.
Intravenous infusion; dose determined by electrolyte and fluid requirements; typical adult dose: 250-1000 mL/hour, not to exceed 30 mL/kg/day.
None Documented
None Documented
Lactate: ~1.5 hours (hepatic conversion); dextrose: ~0.5 hours (insulin-dependent); prolonged in hepatic or renal impairment.
Not applicable as a drug; the half-life of infused crystalloid components is distribution-dependent. Sodium and chloride have a terminal half-life of approximately 2-4 hours in healthy adults, reflecting renal clearance. Clinical context: Half-life prolonged in renal impairment.
Lactate: primarily hepatic metabolism to bicarbonate; renal excretion minimal (<5%). Dextrose: metabolized to CO2 and water; <1% excreted unchanged in urine. Electrolytes: renal excretion proportional to intake.
Renal excretion of electrolytes and water; no hepatic metabolism. >95% of administered water and electrolytes are excreted renally, with small amounts lost via feces (<2%) and insensible losses.
Category C
Category C
Intravenous Fluid
Intravenous Fluid/Electrolyte Solution